HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven Grant Selected Research

Steven Grant Research Topics

Disease

115Neoplasms (Cancer)
02/2023 - 07/2002
81Leukemia
01/2021 - 01/2002
35Multiple Myeloma
12/2022 - 11/2002
26Melanoma (Melanoma, Malignant)
11/2013 - 08/2003
23Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 07/2003
21Carcinoma (Carcinomatosis)
10/2013 - 03/2002
21Mitochondrial Diseases (Mitochondrial Disease)
01/2013 - 01/2002
14Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2019 - 08/2009
13Hematologic Neoplasms (Hematological Malignancy)
07/2020 - 11/2003
13Myeloid Leukemia (Leukemia, Myelocytic)
12/2015 - 01/2002
12Glioblastoma (Glioblastoma Multiforme)
01/2015 - 07/2003
11Breast Neoplasms (Breast Cancer)
10/2013 - 12/2004
10Glioma (Gliomas)
10/2014 - 08/2003
9B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 05/2009
9Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2019 - 12/2002
9Lymphoma (Lymphomas)
05/2017 - 07/2003
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2011 - 07/2004
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018 - 06/2010
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2023 - 12/2009
6Infections
03/2011 - 07/2003
5Prostatic Neoplasms (Prostate Cancer)
05/2012 - 01/2007
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 07/2002
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 12/2002
4Ataxia Telangiectasia (Louis Bar Syndrome)
09/2015 - 04/2003
4Renal Cell Carcinoma (Grawitz Tumor)
11/2013 - 07/2003
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2023 - 01/2015
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2017 - 10/2012
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2014 - 09/2011

Drug/Important Bio-Agent (IBA)

59Histone Deacetylase InhibitorsIBA
01/2023 - 02/2002
38Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2002
32Phosphotransferases (Kinase)IBA
12/2022 - 01/2002
29Bortezomib (Velcade)FDA Link
12/2022 - 10/2003
27VorinostatFDA Link
01/2018 - 12/2003
24alvocidib (flavopiridol)IBA
01/2018 - 02/2002
22Proteasome InhibitorsIBA
06/2019 - 10/2003
21Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2014 - 02/2002
20Sorafenib (BAY 43-9006)FDA Link
01/2015 - 10/2005
20InterleukinsIBA
11/2013 - 08/2003
20CaspasesIBA
02/2013 - 03/2002
19CytokinesIBA
01/2020 - 12/2003
19Imatinib Mesylate (Gleevec)FDA Link
01/2015 - 01/2002
197-hydroxystaurosporine (UCN 01)IBA
05/2013 - 05/2002
17Histone Deacetylases (Histone Deacetylase)IBA
01/2016 - 07/2003
17Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 07/2003
15Butyric Acid (Butanoic Acid)IBA
01/2006 - 02/2002
13Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2012 - 11/2002
13Cytochromes c (Cytochrome c)IBA
07/2007 - 01/2002
12Drug CombinationsIBA
06/2017 - 11/2005
122- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA
04/2012 - 01/2002
11venetoclaxIBA
02/2024 - 01/2018
11CeramidesIBA
07/2012 - 03/2005
9carfilzomibIBA
10/2019 - 06/2010
8DNA (Deoxyribonucleic Acid)IBA
03/2022 - 07/2003
8obatoclaxIBA
10/2013 - 11/2009
7ABT-737IBA
12/2015 - 01/2007
7Caspase 3 (Caspase-3)IBA
06/2008 - 01/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 07/2002
6Cytarabine (Cytosar-U)FDA LinkGeneric
09/2015 - 05/2002
6Lapatinib (GW572016)FDA Link
01/2015 - 11/2009
6Caspase 9IBA
10/2013 - 05/2002
6Interleukin-10 (Interleukin 10)IBA
05/2012 - 05/2010
6Cytotoxins (Cytolysins)IBA
01/2012 - 02/2003
6tanespimycin (17AAG)IBA
03/2011 - 09/2003
6Mitogen-Activated Protein KinasesIBA
05/2010 - 01/2002
6Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2010 - 01/2002
6bryostatin 1IBA
10/2006 - 05/2002
6Protein Kinase CIBA
03/2005 - 05/2002
5Azacitidine (5 Azacytidine)FDA Link
02/2024 - 02/2023
5belinostatIBA
01/2023 - 01/2008
5AZD 6244IBA
03/2016 - 03/2008
5OSU 03012IBA
10/2014 - 08/2006
5Small Interfering RNA (siRNA)IBA
09/2014 - 08/2004
5AD 5IBA
11/2013 - 06/2010
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2012 - 01/2002
5fludarabineIBA
04/2012 - 12/2002
5entinostat (MS 275)IBA
09/2011 - 07/2003
5Caspase 8 (Caspase-8)IBA
03/2011 - 05/2002
5Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2010 - 09/2003
5NF-kappa B (NF-kB)IBA
03/2010 - 09/2003
5Mitogen-Activated Protein Kinase 3IBA
11/2009 - 02/2005
5U 0126 (UO 126)IBA
11/2009 - 11/2002
4DecitabineFDA Link
02/2024 - 05/2023
4LigandsIBA
12/2022 - 12/2003
4PanobinostatIBA
10/2021 - 04/2012
4Apoptosis Regulatory ProteinsIBA
08/2017 - 02/2006
4romidepsin (FK228)FDA Link
01/2017 - 01/2008
4Valproic Acid (Depakote)FDA LinkGeneric
05/2014 - 08/2009
4Endoplasmic Reticulum Chaperone BiPIBA
03/2014 - 05/2010
4Checkpoint Kinase 1IBA
08/2012 - 12/2006
4RoscovitineIBA
01/2007 - 04/2003
3RNA Polymerase II (RNA Polymerase B)IBA
10/2019 - 04/2013
3EnzymesIBA
01/2016 - 06/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 06/2005
3Dasatinib (BMS 354825)FDA Link
01/2015 - 05/2007
3Rituximab (Mabthera)FDA Link
11/2014 - 10/2006
3Death Domain ReceptorsIBA
10/2014 - 05/2010
3Phosphodiesterase 5 InhibitorsIBA
10/2014 - 03/2014

Therapy/Procedure

51Therapeutics
02/2024 - 01/2003
11Drug Therapy (Chemotherapy)
06/2014 - 02/2003
5Radiotherapy
02/2012 - 07/2003